Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause

  • National and Kapodistrian University of Athens ROR
  • Centre for Human Reproduction, Genesis Athens Clinic, 14-16, Papanikoli, 15232 Athens, Greece
  • Centre for Human Reproduction, Genesis Athens Clinic, Greece
  • Microbiology-Biochemical Department, Genesis Athens Clinic, Greece

Journal of Clinical Medicine, 8(1), E1

DOI 10.3390/jcm8010001 PMID 30577435

Abstract

This report presents the case of a woman aged 40 who has experienced premature menopause from the age of 35. Having rejected oocyte donation, she opted for intraovarian injection of autologous platelet-rich plasma with the aim to rejuvenate the ovarian tissue and enable the employment of her own gametes through in-vitro fertilization. Six weeks following the autologous platelet-rich plasma treatment, a significant reduction in the patient's follicle-stimulating hormone (FSH) levels were noted. A natural in-vitro fertilization cycle led to a biochemical pregnancy, resulting in a spontaneous abortion at the 5th week of pregnancy. This is the first report of a successful autologous platelet-rich plasma application leading to pregnancy in menopause. This report uniquely contributes to the medical knowledge and challenges current practice in the context of infertility. The efficiency and safety of this treatment with regard to the reproductive system merits further investigation.

Topics

Sfakianoudis Simopoulou intraovarian platelet-rich plasma premature menopause pregnancy, PRP ovarian rejuvenation FSH 149 mIU/mL AMH 0.02 ng/mL case report, autologous PRP injection ovarian tissue growth factors IGF-1 TGF-beta regeneration, premature ovarian failure age 35 oocyte donation rejected natural IVF cycle, biochemical pregnancy after PRP treatment spontaneous abortion fifth week, GDF-9 biomarker oocyte maturation platelet-derived growth factors angiogenesis, Genesis Athens Clinic premature menopause fertility restoration autologous gametes, first case report PRP leading to pregnancy in premature menopause, follicle-stimulating hormone reduction six weeks after intraovarian PRP injection, ovarian reserve depletion experimental rejuvenation therapy reproductive medicine
PMID 30577435 30577435 DOI 10.3390/jcm8010001 10.3390/jcm8010001

Cite this article

Sfakianoudis, K., Simopoulou, M., Nitsos, N., Rapani, A., Pappas, A., Pantou, A., Chronopoulou, M., Deligeoroglou, E., Koutsilieris, M., & Pantos, K. (2018). Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause. *Journal of clinical medicine*, *8*(1), E1. https://doi.org/10.3390/jcm8010001

Related articles